[The significance of endorphins and gamma-aminobutyric acid in clinical psychopharmacology (author's transl)].
D001007:Anxiety / Q000378:metabolism; D001714:Bipolar Disorder / Q000517:prevention & control; D003677:Deficiency Diseases / Q000150:complications; D003863:Depression / Q000378:metabolism; D004723:Endorphins / Q000172:deficiency / Q000378:metabolism*; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy / Q000378:metabolism*; D009270:Naloxone / Q000378:metabolism; D012559:Schizophrenia / Q000209:etiology / Q000378:metabolism; D005680:gamma-Aminobutyric Acid / Q000378:metabolism* / Q000627:therapeutic use
D004723:Endorphins; D009270:Naloxone; D005680:gamma-Aminobutyric Acid
Význam endorfinů a gama-aminomáslené kyseliny pro klinickou psychofarmakologii. Souborný referát.